Otherwise, necrostatin-1, an inhibitor of receptor-interacting serine/threonine-protein kinase 1 (RIPK1) and necrosis, shows positive effects for delaying the onset and improving motor behaviors while the survival extension is not improved in HD transgenic (R6/2) mice [77,233,234]. This evidence concerns the gene RIPK1 and Huntington disease.